Cargando…

Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer

Disrupted circadian rhythmicity is a prominent feature of modern society and has been designated as a probable carcinogen by the World Health Organization. However, the biological mechanisms that connect circadian disruption and cancer risk remain largely undefined. We demonstrate that exposure to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariollaud, Marie, Ibrahim, Lara H., Irizarry, Emanuel, Mello, Rebecca M., Chan, Alanna B., Altman, Brian J., Shaw, Reuben J., Bollong, Michael J., Wiseman, R. Luke, Lamia, Katja A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519049/
https://www.ncbi.nlm.nih.gov/pubmed/36170373
http://dx.doi.org/10.1126/sciadv.abo1123
_version_ 1784799318830481408
author Pariollaud, Marie
Ibrahim, Lara H.
Irizarry, Emanuel
Mello, Rebecca M.
Chan, Alanna B.
Altman, Brian J.
Shaw, Reuben J.
Bollong, Michael J.
Wiseman, R. Luke
Lamia, Katja A.
author_facet Pariollaud, Marie
Ibrahim, Lara H.
Irizarry, Emanuel
Mello, Rebecca M.
Chan, Alanna B.
Altman, Brian J.
Shaw, Reuben J.
Bollong, Michael J.
Wiseman, R. Luke
Lamia, Katja A.
author_sort Pariollaud, Marie
collection PubMed
description Disrupted circadian rhythmicity is a prominent feature of modern society and has been designated as a probable carcinogen by the World Health Organization. However, the biological mechanisms that connect circadian disruption and cancer risk remain largely undefined. We demonstrate that exposure to chronic circadian disruption [chronic jetlag (CJL)] increases tumor burden in a mouse model of KRAS-driven lung cancer. Molecular characterization of tumors and tumor-bearing lung tissues revealed that CJL enhances the expression of heat shock factor 1 (HSF1) target genes. Consistently, exposure to CJL disrupted the highly rhythmic nuclear trafficking of HSF1 in the lung, resulting in an enhanced accumulation of HSF1 in the nucleus. HSF1 has been shown to promote tumorigenesis in other systems, and we find that pharmacological or genetic inhibition of HSF1 reduces the growth of KRAS-mutant human lung cancer cells. These findings implicate HSF1 as a molecular link between circadian disruption and enhanced tumorigenesis.
format Online
Article
Text
id pubmed-9519049
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-95190492022-10-13 Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer Pariollaud, Marie Ibrahim, Lara H. Irizarry, Emanuel Mello, Rebecca M. Chan, Alanna B. Altman, Brian J. Shaw, Reuben J. Bollong, Michael J. Wiseman, R. Luke Lamia, Katja A. Sci Adv Biomedicine and Life Sciences Disrupted circadian rhythmicity is a prominent feature of modern society and has been designated as a probable carcinogen by the World Health Organization. However, the biological mechanisms that connect circadian disruption and cancer risk remain largely undefined. We demonstrate that exposure to chronic circadian disruption [chronic jetlag (CJL)] increases tumor burden in a mouse model of KRAS-driven lung cancer. Molecular characterization of tumors and tumor-bearing lung tissues revealed that CJL enhances the expression of heat shock factor 1 (HSF1) target genes. Consistently, exposure to CJL disrupted the highly rhythmic nuclear trafficking of HSF1 in the lung, resulting in an enhanced accumulation of HSF1 in the nucleus. HSF1 has been shown to promote tumorigenesis in other systems, and we find that pharmacological or genetic inhibition of HSF1 reduces the growth of KRAS-mutant human lung cancer cells. These findings implicate HSF1 as a molecular link between circadian disruption and enhanced tumorigenesis. American Association for the Advancement of Science 2022-09-28 /pmc/articles/PMC9519049/ /pubmed/36170373 http://dx.doi.org/10.1126/sciadv.abo1123 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Pariollaud, Marie
Ibrahim, Lara H.
Irizarry, Emanuel
Mello, Rebecca M.
Chan, Alanna B.
Altman, Brian J.
Shaw, Reuben J.
Bollong, Michael J.
Wiseman, R. Luke
Lamia, Katja A.
Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title_full Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title_fullStr Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title_full_unstemmed Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title_short Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
title_sort circadian disruption enhances hsf1 signaling and tumorigenesis in kras-driven lung cancer
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519049/
https://www.ncbi.nlm.nih.gov/pubmed/36170373
http://dx.doi.org/10.1126/sciadv.abo1123
work_keys_str_mv AT pariollaudmarie circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT ibrahimlarah circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT irizarryemanuel circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT mellorebeccam circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT chanalannab circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT altmanbrianj circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT shawreubenj circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT bollongmichaelj circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT wisemanrluke circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer
AT lamiakatjaa circadiandisruptionenhanceshsf1signalingandtumorigenesisinkrasdrivenlungcancer